How many employees work at Cha Biotech?

About Cha Biotech

The Cha Bio Group continues to challenge the best in the bio and healthcare industry. We are developing high -tech biopharmaceuticals such as cells and gene therapies, next -generation vaccines, and targeted anticancer drugs with differentiated R & D capabilities such as the only industrial, academia, research, and bottles of Korea, the world's largest cell library, and immune enhancement platform. Chabio Group is maximizing business through vertical integration of companies such as Chabiotech, CMG Pharmaceuticals, Chapter Healthcare, Cha Meditech, Cha Bio F & C, Cha Bio F & C, Cha Cares, Seoul CRO, and Soliders Investment. The challenge and innovation of the Cha Bio Group continues. The company has been in full -fledged CGT CDMO project through Matica Biotechnology, USA, and has entered the US, Australia, Japan, and Southeast Asia, starting with Los Angeles Hollywood tea hospitals to lead the medical Korean Wave. Cha Bio Group is Continuing its Challenge to beCome the Best in Various Initial Achievements in the bio and Healthcare Fields. We are developing and producting Advanced Biopharmaceuticals, Including Cell and Gene Therapy Products and Vaccines CAPABILITIES, SUCH AS OUR Unique ‘CHA BIO ECOSYSTEM: Academic, Research, Medical Network, and Bio-Industry Business And our independently developed Vaccine Adjuvant Platform. We will LEAP forward as a True Global Bio Company Centered on the Third-Generation CGT CDMO and Global Healthcare Business.